Boxer Erik "El Terrible" Morales accused of doping

Tested positive for clenbuterol

MEXICO. - The president of the World Boxing Council, Jose Sulaiman, defended former world champ Erik Morales against the U.S. Anti-Doping Agency on accusations of using "clenbuterol."

Sulaiman said that if the Boxing Commission of New York, who sanctioned the fight against Danny Garcia Morales, reported no positive drug test results, then the WBC has nothing to pursue against Morales.

"We follow our rules and if the Boxing Commission of New York does not indicate any positive results, then there's nothing here," said Sulaiman in a press conference.

Morales was accused by USADA after having tested positive for clenbuterol before his fight on October 20, 2012 against Danny Garcia, where he lost by knockout in four rounds.

Sulaiman said the accusations "have no grounds and are even laughable." The only thing that the USADA is doing here is staining Morales career, and added that the "Mexican boxing idol" has never been involved in problems of this type.

"The fact that they are messing with the image, credibility and respect that a champion should have, and of someone who has been a Mexican hero and has had a clean professional life, does not seem right. It is an exaggeration and an abuse of power" he added.

Sulaiman said that USADA follows the rules of the World Anti-Doping Agency (WADA), but "has nothing to do with the Boxing Commission of New York, who the WBC answers only to the Commission."

He explained that the WBC cannot do doping tests abroad, but if the Boxing Commission of New York found that there was nothing, then there is nothing to report.

In the days before the bout, Morales had tested positive for clenbuterol, but the commission said the fighter's level of concentration of this substance in the samples taken in Mexico were very low and let him fight.

A third test was requested by Danny Garcia, which Morales accepted to do and tested negative for any trace of the substance.



  • Facebook

  • SanDiegoRed

  • New

  • Best

    Recent News more